Back to search

Belgium· BE-AMP-SAM587280-00

Celsunax 74 MBq/ml

A iodine ioflupane (123i) product containing ioflupane (i-123), registered in Belgium by Pinax Pharma. The same ATC class is registered in 11 of our 19 countries.

ATC V09AB03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCelsunax 74 MBq/mlATCV09AB03REGISTER NO.BE-AMP-SAM587280-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Iodine ioflupane (123i) is registered in 11 of 19 countries.

Countries holding a registration under ATC V09AB03 (iodine ioflupane (123i)), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Iodine ioflupane (123i) · ATC V09AB03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ioflupane (I-123)
Manufacturer
Pinax Pharma
Country
Belgium (BE)
ATC code
V09AB03
ATC class
Iodine ioflupane (123I)
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Iodine ioflupane (123i) in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iodine ioflupane (123i) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ddd8f3a2-f6c3-4af3-85d2-3786f8f8e1ae
GET /v1/drugs/ddd8f3a2-f6c3-4af3-85d2-3786f8f8e1ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Celsunax 74 MBq/ml",
  "name_fr": "Celsunax 74 MBq/ml",
  "name_nl": "Celsunax 74 MBq/ml",
  "amp_code": "SAM587280-00",
  "strengths": [
    "74.0000",
    "39.5000"
  ],
  "pack_count": 2,
  "substances": [
    "Ioflupane (I-123)",
    "Ethanol",
    "Sodium Acetate Trihydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Iodine Ioflupane (123I)",
  "authorisation_numbers": [
    "EU/1/21/1560/002",
    "EU/1/21/1560/001"
  ]
}

See everything about iodine ioflupane (123i).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.